Kyushu University
Clinical trials sponsored by Kyushu University, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New hope for kids with tough cancers: GAIA-102 trial launches Results expected Aug 2027 (estimated)
-
Can a statin nanoparticle save sight in retinitis pigmentosa?
Disease control Not yet recruitingThis phase 1 trial tests whether an intravenous nanoparticle formulation of pitavastatin, called ULREA-PVS-NP, is safe in adults with retinitis pigmentosa, a rare inherited disease that causes progressive vision loss. The study aims to see if the treatment can reduce retinal infl…
Phase 1 • Sponsor: Kyushu University • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Can a new drug combo curb devastating NMOSD Flare-Ups?
Disease control Not yet recruitingThis early-stage trial is testing whether adding the drug sivelestat to standard steroid therapy is safe and may help people during an acute attack of neuromyelitis optica spectrum disorder (NMOSD), a rare autoimmune condition that can cause vision loss and paralysis. Seven parti…
Phase 1/2 • Sponsor: Kyushu University • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC